329217-74-5 Usage
Uses
Used in Organic Synthesis:
6-Bromo-5-methoxypicolinaldehyde is used as a building block in the synthesis of various organic compounds. Its unique structural properties, including the bromine atom and methoxy group, contribute to its versatile reactivity, making it a valuable component in the creation of new molecules with potential applications in various industries.
Used in Pharmaceutical Compounds:
In the pharmaceutical industry, 6-Bromo-5-methoxypicolinaldehyde is utilized as a key intermediate in the development of new drugs. Its potential biological activities and compatibility with other chemical entities make it a promising candidate for the synthesis of novel therapeutic agents.
Used in Medicinal Chemistry:
6-Bromo-5-methoxypicolinaldehyde is employed in medicinal chemistry for its potential applications in drug development. Researchers explore its interactions with biological targets and evaluate its efficacy in treating various diseases, leveraging its unique structural features to design innovative pharmaceutical agents.
Used in Drug Development:
In the realm of drug development, 6-Bromo-5-methoxypicolinaldehyde serves as a valuable precursor in the creation of new therapeutic agents. Its potential biological activities and compatibility with other chemical entities make it an attractive candidate for the development of novel drugs with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 329217-74-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,9,2,1 and 7 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 329217-74:
(8*3)+(7*2)+(6*9)+(5*2)+(4*1)+(3*7)+(2*7)+(1*4)=145
145 % 10 = 5
So 329217-74-5 is a valid CAS Registry Number.
329217-74-5Relevant academic research and scientific papers
BIARYL DERIVATIVES AS BROMODOMAIN INHIBITORS
-
, (2014/05/25)
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
CYCLIC AMINES AS BROMODOMAIN INHIBITORS
-
, (2014/05/25)
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
-
, (2008/06/13)
The present invention relates to compounds of Formula (I) which may be useful in the treatment of diseases, such as, metabolic disorders, dyslipidemia and/or hyperchloesterolemia: 1
Heterocyclic derivatives for the treatment of diabetes and other diseases
-
, (2008/06/13)
The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.
